SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Schiele B.)
 

Sökning: WFRF:(Schiele B.) > Euro Heart Survey 2...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00003907naa a2200577 4500
001oai:DiVA.org:uu-241190
003SwePub
008150108s2013 | |||||||||||000 ||eng|
024a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-2411902 URI
024a https://doi.org/10.1177/20488726134973412 DOI
040 a (SwePub)uu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Puymirat, E4 aut
2451 0a Euro Heart Survey 2009 Snapshot :b regional variations in presentation and management of patients with AMI in 47 countries
264 c 2013-08-20
264 1b Oxford University Press (OUP),c 2013
338 a print2 rdacarrier
520 a AIMS:Detailed data on patients admitted for acute myocardial infarction (AMI) on a European-wide basis are lacking. The Euro Heart Survey 2009 Snapshot was designed to assess characteristics, management, and hospital outcomes of AMI patients throughout European Society of Cardiology (ESC) member countries in a contemporary 'real-world' setting, using a methodology designed to improve the representativeness of the survey.METHODS:Member countries of the ESC were invited to participate in a 1-week survey of all patients admitted for documented AMI in December 2009. Data on baseline characteristics, type of AMI, management, and complications were recorded using a dedicated electronic form. In addition, we used data collected during the same time period in national registries in Sweden, England, and Wales. Data were centralized at the European Heart House.RESULTS:Overall, 4236 patients (mean age 66±13 years; 31% women) were included in the study in 47 countries. Sixty per cent of patients had ST-segment elevation myocardial infarction, with 50% having primary percutaneous coronary intervention and 21% fibrinolysis. Aspirin and thienopyridines were used in >90%. Unfractionated and low-molecular-weight heparins were the most commonly used anticoagulants. Statins, beta-blockers, and angiotensin-converting enzyme inhibitors were used in >80% of the patients. In-hospital mortality was 6.2%. Regional differences were observed, both in terms of population characteristics, management, and outcomes.CONCLUSIONS:In-hospital mortality of patients admitted for AMI in Europe is low. Although regional variations exist in their presentation and management, differences are limited and have only moderate impact on early outcomes.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng
700a Battler, A4 aut
700a Birkhead, J4 aut
700a Bueno, H4 aut
700a Clemmensen, P4 aut
700a Cottin, Y4 aut
700a Fox, Keith AA4 aut
700a Gorenek, B4 aut
700a Hamm, C4 aut
700a Huber, Kurt4 aut
700a Lettino, M4 aut
700a Lindahl, Bertilu Uppsala universitet,Kardiologi,Uppsala kliniska forskningscentrum (UCR)4 aut0 (Swepub:uu)belin227
700a Mueller, C4 aut
700a Parkhomenko, A4 aut
700a Price, S4 aut
700a Quinn, T4 aut
700a Schiele, F4 aut
700a Simoons, M4 aut
700a Tatu-Chitoiu, G4 aut
700a Tubaro, M4 aut
700a Vrints, C4 aut
700a Zahger, D4 aut
700a Zeymer, U4 aut
700a Danchin, N4 aut
710a Uppsala universitetb Kardiologi4 org
773t European Heart Journald : Oxford University Press (OUP)g 2:4, s. 359-370q 2:4<359-370x 2048-8726x 2048-8734
856u https://europepmc.org/articles/pmc3821830?pdf=render
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-241190
8564 8u https://doi.org/10.1177/2048872613497341

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy